Table 1.
Clinical characteristics of CVA and control subjects
| Characteristics | CVA (n = 27) | Controls (n = 232) | P value |
|---|---|---|---|
| Age (years) | 46.79 ± 11.82 | 51.37 ± 13.24 | 0.0868 |
| Gender (% male) | 51.85 | 61.64 | 0.3246 |
| SBP (mmHg) | 114.38 ± 21.36 | 123.46 ± 23.75 | 0.0587 |
| DBP (mmHg) | 75.43 ± 9.64 | 79.51 ± 10.39 | 0.0529 |
| BMI (Kg/m2) | 23.49 ± 1.65 | 23.13 ± 1.58 | 0.2657 |
| LVEF (%) | 60.12 ± 6.57 | 62.38 ± 6.84 | 0.1041 |
| TC (mmol/L) | 5.05 ± 0.72 | 4.86 ± 0.60 | 0.1288 |
| LDL-C (mmol/L) | 2.63 ± 0.88 | 2.54 ± 0.52 | 0.4357 |
| HDL-C (mmol/L) | 1.40 ± 0.28 | 1.46 ± 0.32 | 0.3516 |
| TG (mmol/L) | 1.57 ± 0.55 | 1.66 ± 0.68 | 0.5082 |
| IL-6 (pg/mL) | 3.18 ± 0.88 | 2.66 ± 0.73 | 0.0007 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; LVEF, left ventricular ejection fraction; TC, total cholesterol; LDL-C, low density lipoprotein-cholesterol; HDL-C, high density lipoprotein-cholesterol; TG, triglycerides; IL-6, interleukin-6.